_id

69105baaccc777a4e85d580e

Ticker

DMAC

Name

DiaMedica Therapeutics Inc

Exchange

NASDAQ

Address

301 Carlson Parkway, Minneapolis, MN, United States, 55305

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.diamedica.com

Description

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company also develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Last Close

9.34

Volume

239776

Current Price

9.39

Change

0.5353319057815922

Last Updated

2025-11-29T12:17:43.881Z

Image

-

Ipo Date

2008-01-04T00:00:00.000Z

Market Cap

449428320

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.99

Sentiment Sources

2

Rating

4.75

Target Price

15.5

Strong Buy

3

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

18000

Gross Profit

-18000

Operating Expenses

9015000

Operating Income

-9033000

Interest Expense

-

Pretax Income

-8614000

Net Income

-8620000

Eps

-0.17368485455374386

Dividends Per Share

-

Shares Outstanding

52077439

Income Tax Expense

6000

EBITDA

-8596000

Operating Margin

-

Total Other Income Expense Net

419000

Cash

3326000

Short Term Investments

51992000

Receivables

260000

Inventories

-

Total Current Assets

56223000

Property Plant Equipment

368000

Total Assets

57047000

Payables

1920000

Short Term Debt

109000

Long Term Debt

-

Total Liabilities

5425000

Equity

51622000

Depreciation

18000

Change In Working Capital

1285032

Cash From Operations

-6604860

Capital Expenditures

16189

Cash From Investing

-26205409

Cash From Financing

32012062

Net Change In Cash

-783000

PE

-

PB

9.027678458990353

ROE

-16.69830692340475

ROA

-15.11034760811261

FCF

-6621049

Fcf Percent

-

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

18000

Quarters > 0 > income Statement > gross Profit

-18000

Quarters > 0 > income Statement > operating Expenses

9015000

Quarters > 0 > income Statement > operating Income

-9033000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-8614000

Quarters > 0 > income Statement > net Income

-8620000

Quarters > 0 > income Statement > eps

-0.17368485455374386

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

49630119

Quarters > 0 > income Statement > income Tax Expense

6000

Quarters > 0 > income Statement > EBITDA

-8596000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

419000

Quarters > 0 > balance Sheet > cash

3326000

Quarters > 0 > balance Sheet > short Term Investments

51992000

Quarters > 0 > balance Sheet > receivables

260000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

56223000

Quarters > 0 > balance Sheet > property Plant Equipment

368000

Quarters > 0 > balance Sheet > total Assets

57047000

Quarters > 0 > balance Sheet > payables

1920000

Quarters > 0 > balance Sheet > short Term Debt

109000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

5425000

Quarters > 0 > balance Sheet > equity

51622000

Quarters > 0 > cash Flow > net Income

-8620000

Quarters > 0 > cash Flow > depreciation

18000

Quarters > 0 > cash Flow > change In Working Capital

1285032

Quarters > 0 > cash Flow > cash From Operations

-6604860

Quarters > 0 > cash Flow > capital Expenditures

16189

Quarters > 0 > cash Flow > cash From Investing

-26205409

Quarters > 0 > cash Flow > cash From Financing

32012062

Quarters > 0 > cash Flow > net Change In Cash

-783000

Quarters > 0 > ratios > PE

-0.17368485455374386

Quarters > 0 > ratios > PB

9.027678458990353

Quarters > 0 > ratios > ROE

-16.69830692340475

Quarters > 0 > ratios > ROA

-15.11034760811261

Quarters > 0 > ratios > FCF

-6621049

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

3000

Quarters > 1 > income Statement > gross Profit

-3000

Quarters > 1 > income Statement > operating Expenses

8007000

Quarters > 1 > income Statement > operating Income

-8007000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-7693000

Quarters > 1 > income Statement > net Income

-7699000

Quarters > 1 > income Statement > eps

-0.17922315480287676

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

42957619

Quarters > 1 > income Statement > income Tax Expense

6000

Quarters > 1 > income Statement > EBITDA

-8004000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

314000

Quarters > 1 > balance Sheet > cash

4109000

Quarters > 1 > balance Sheet > short Term Investments

25929000

Quarters > 1 > balance Sheet > receivables

161000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

31079000

Quarters > 1 > balance Sheet > property Plant Equipment

391000

Quarters > 1 > balance Sheet > total Assets

31470000

Quarters > 1 > balance Sheet > payables

1261000

Quarters > 1 > balance Sheet > short Term Debt

108000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

4300000

Quarters > 1 > balance Sheet > equity

27170000

Quarters > 1 > cash Flow > net Income

-7699000

Quarters > 1 > cash Flow > depreciation

3000

Quarters > 1 > cash Flow > change In Working Capital

-513000

Quarters > 1 > cash Flow > cash From Operations

-7598000

Quarters > 1 > cash Flow > capital Expenditures

6000

Quarters > 1 > cash Flow > cash From Investing

8957000

Quarters > 1 > cash Flow > cash From Financing

161000

Quarters > 1 > cash Flow > net Change In Cash

1520000

Quarters > 1 > ratios > PE

-0.17922315480287676

Quarters > 1 > ratios > PB

14.846229017666545

Quarters > 1 > ratios > ROE

-28.3364004416636

Quarters > 1 > ratios > ROA

-24.46456943120432

Quarters > 1 > ratios > FCF

-7604000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

11000

Quarters > 2 > income Statement > gross Profit

-11000

Quarters > 2 > income Statement > operating Expenses

8144000

Quarters > 2 > income Statement > operating Income

-8144000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-7701000

Quarters > 2 > income Statement > net Income

-7707000

Quarters > 2 > income Statement > eps

-0.179885425097945

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

42843938

Quarters > 2 > income Statement > income Tax Expense

6000

Quarters > 2 > income Statement > EBITDA

-8133000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

443000

Quarters > 2 > balance Sheet > cash

2589000

Quarters > 2 > balance Sheet > short Term Investments

33731000

Quarters > 2 > balance Sheet > receivables

253000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

37422000

Quarters > 2 > balance Sheet > property Plant Equipment

408000

Quarters > 2 > balance Sheet > total Assets

38830000

Quarters > 2 > balance Sheet > payables

1507000

Quarters > 2 > balance Sheet > short Term Debt

105000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

4876000

Quarters > 2 > balance Sheet > equity

33954000

Quarters > 2 > cash Flow > net Income

-7707000

Quarters > 2 > cash Flow > depreciation

11000

Quarters > 2 > cash Flow > change In Working Capital

-79000

Quarters > 2 > cash Flow > cash From Operations

-7149000

Quarters > 2 > cash Flow > capital Expenditures

12000

Quarters > 2 > cash Flow > cash From Investing

6622000

Quarters > 2 > cash Flow > cash From Financing

91000

Quarters > 2 > cash Flow > net Change In Cash

-436000

Quarters > 2 > ratios > PE

-0.179885425097945

Quarters > 2 > ratios > PB

11.848517930729813

Quarters > 2 > ratios > ROE

-22.698356600106028

Quarters > 2 > ratios > ROA

-19.848055627092453

Quarters > 2 > ratios > FCF

-7161000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

35

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

13802000

Quarters > 3 > income Statement > cost Of Revenue

11000

Quarters > 3 > income Statement > gross Profit

-11000

Quarters > 3 > income Statement > operating Expenses

8408000

Quarters > 3 > income Statement > operating Income

-8419000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-7891000

Quarters > 3 > income Statement > net Income

-7900000

Quarters > 3 > income Statement > eps

-0.18449900113642043

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

42818660

Quarters > 3 > income Statement > income Tax Expense

9000

Quarters > 3 > income Statement > EBITDA

-7880000

Quarters > 3 > income Statement > operating Margin

-60.99840602811186

Quarters > 3 > income Statement > total Other Income Expense Net

528000

Quarters > 3 > balance Sheet > cash

3025000

Quarters > 3 > balance Sheet > short Term Investments

41122000

Quarters > 3 > balance Sheet > receivables

236000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

44610000

Quarters > 3 > balance Sheet > property Plant Equipment

427000

Quarters > 3 > balance Sheet > total Assets

46345000

Quarters > 3 > balance Sheet > payables

940000

Quarters > 3 > balance Sheet > short Term Debt

103000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

5627000

Quarters > 3 > balance Sheet > equity

40718000

Quarters > 3 > cash Flow > net Income

-7900000

Quarters > 3 > cash Flow > depreciation

11000

Quarters > 3 > cash Flow > change In Working Capital

1177000

Quarters > 3 > cash Flow > cash From Operations

-6434000

Quarters > 3 > cash Flow > capital Expenditures

7000

Quarters > 3 > cash Flow > cash From Investing

5205000

Quarters > 3 > cash Flow > cash From Financing

120000

Quarters > 3 > cash Flow > net Change In Cash

-1109000

Quarters > 3 > ratios > PE

-0.18449900113642043

Quarters > 3 > ratios > PB

9.874434338621741

Quarters > 3 > ratios > ROE

-19.40173878874208

Quarters > 3 > ratios > ROA

-17.046067536951128

Quarters > 3 > ratios > FCF

-6441000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.4666714968845095

Quarters > 3 > health Score

27

Valuation > metrics > PE

-0.17368485455374386

Valuation > metrics > PB

9.027678458990353

Valuation > final Score

20

Valuation > verdict

200.9% Overvalued

Profitability > metrics > ROE

-16.69830692340475

Profitability > metrics > ROA

-15.331803710225353

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.10509085273720507

Risk > metrics > Interest Coverage

-501.8333333333333

Risk > final Score

-1947

Risk > verdict

High

Liquidity > metrics > Current Ratio

27.70970921636274

Liquidity > metrics > Quick Ratio

27.70970921636274

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-43

Prev Risks > 1

-15

Prev Risks > 2

-3001

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:23:45.586Z